Cell  
Attenuon Home Page
spacer

Active Trials: ATN-161

Protocol ATN-161-002 (Glioma)
Protocol Title A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma
Objectives
  • (Phase I) To establish the safety of the combination of ATN-161 and carboplatin and to determine the dose of ATN-161 and carboplatin to be used in the Phase II portion of the study.
  • (Phase II) To determine the anti-tumor activity of ATN-161 in combination with carboplatin in patients with recurrent malignant gliomas.

Patient Population Adult patients with recurrent intracranial malignant glioma.
Study Status Recruiting

Click here to view current investigational sites at www.clinicaltrials.gov

 

 

 

   
  Home / Company / Technology / Trials / News / Contact Us / 
Copyright  © 2007 Attenuon, LLC, All Rights Reserved.  Click for Legal Notice